✦ LIBER ✦

PDB31 A LIFETIME MODELLED ECONOMIC EVALUATION COMPARING PIOGLITAZONE AND ROSIGLITAZONE FORTHE TREATMENT OF TYPE-2 DIABETES MELLITUS IN THE UK

✍ Scribed by D Tilden; S Mariz; A Diamantopoulos; G O'Bryan-Tear

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB82 Development of a Health Economic M

✍ Nagy, B.; Nagyjanosi, L.; Nagyistok, S.; Józwiak-Hagymásy, J.; Dessewffy, Z.; Ka 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PDB43 Economic Evaluation of Vildaglipti

✍ Hatzikou, M.; Rombopoulos, G.; Yfantopoulos, J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PDB21 ECONOMIC EVALUATION OF RAPID-ACTIN

✍ D Belanger; CG Cameron 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

PDB22 ECONOMIC EVALUATION OF LONG-ACTING

✍ D Belanger; CG Cameron 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Economic Evaluation of Liraglutide for T

✍ Yagudina, R.; Kulikov, A.; Novikov, I. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

PDB67 PATIENT-CENTERED OUTCOMES IN THE E

✍ WK Redekop; D Cobden; L Niessen; F Rutten 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB